130 related articles for article (PubMed ID: 11479153)
1. Nephromegaly and elevated plasma hepatocyte growth factor-transforming growth factor-beta1 ratio in infants with fulminant hepatitis or biliary atresia.
Tsau YK; Lu MY; Ni YH
Am J Kidney Dis; 2001 Aug; 38(2):279-85. PubMed ID: 11479153
[TBL] [Abstract][Full Text] [Related]
2. Kidney volume and plasma hepatocyte growth factor-transforming growth factor beta1 ratio among children with biliary atresia before and after liver transplantation: the reversibility of nephromegaly.
Cheng CH; Tsau YK; Tsai IJ
Am J Kidney Dis; 2005 Nov; 46(5):830-6. PubMed ID: 16253722
[TBL] [Abstract][Full Text] [Related]
3. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
Tsau YK; Jou ST; Ni YH
Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
[TBL] [Abstract][Full Text] [Related]
4. Nephromegaly and elevated hepatocyte growth factor in children with biliary atresia.
Tsau YK; Chen CH; Chang MH; Teng RJ; Lu MY; Lee PI
Am J Kidney Dis; 1997 Feb; 29(2):188-92. PubMed ID: 9016888
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor-β1 and connective tissue growth factor in congenital biliary atresia and neonatal hepatitis liver tissue.
Li FB; Zhao H; Peng KR; Gao ZG; Huang SJ; Tou JF; Shu XL; Gu WZ
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909983
[TBL] [Abstract][Full Text] [Related]
6. Transient reciprocal change of renal hepatocyte growth factor and transforming growth factor-beta1 may relate to renal hypertrophy in rats with liver injury or unilateral nephrectomy.
Tsau YK; Tsai IJ; Chen YM
Pediatr Res; 2006 Apr; 59(4 Pt 1):494-9. PubMed ID: 16549518
[TBL] [Abstract][Full Text] [Related]
7. Nephromegaly in children with Kawasaki disease: new supporting evidence for diagnosis and its possible mechanism.
Huang HP; Lai YC; Tsai IJ; Chen SY; Cheng CH; Tsau YK
Pediatr Res; 2008 Feb; 63(2):207-10. PubMed ID: 18091351
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease.
Sturm A; Schulte C; Schatton R; Becker A; Cario E; Goebell H; Dignass AU
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):445-50. PubMed ID: 10783999
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hepatocyte growth factor in patients with biliary atresia.
Hsieh CS; Huang LT; Lee SY; Huang CC; Lee CL; Chuang JH; Chen CL
J Pediatr Surg; 2008 Jul; 43(7):1333-7. PubMed ID: 18639691
[TBL] [Abstract][Full Text] [Related]
12. Serum hepatocyte growth factor and clinical outcome in biliary atresia.
Vejchapipat P; Theamboonlers A; Chaokhonchai R; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
J Pediatr Surg; 2004 Jul; 39(7):1045-9. PubMed ID: 15213896
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor levels in livers and serum at Kasai-portoenterostomy are not predictive of clinical outcome in infants with biliary atresia.
Madadi-Sanjani O; Kuebler JF; Dippel S; Gigina A; Falk CS; Vieten G; Petersen C; Klemann C
Growth Factors; 2019 Apr; 37(1-2):68-75. PubMed ID: 31185750
[TBL] [Abstract][Full Text] [Related]
14. The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia.
Uchida K; Inoue M; Otake K; Yoshiyama S; Toiyama Y; Hiro J; Araki T; Miki C; Kusunoki M
J Pediatr Surg; 2006 Oct; 41(10):1657-62. PubMed ID: 17011264
[TBL] [Abstract][Full Text] [Related]
15. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
16. Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome.
Zhou K; Wang J; Xie G; Zhou Y; Yan W; Pan W; Che Y; Zhang T; Wong L; Kwee S; Xiao Y; Wen J; Cai W; Jia W
J Proteome Res; 2015 Nov; 14(11):4844-50. PubMed ID: 26449593
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation.
Ninomiya M; Harada N; Shiotani S; Hiroshige S; Minagawa R; Soejima Y; Suehiro T; Nishizaki T; Shimada M; Sugimachi K
Transpl Int; 2003 Nov; 16(11):814-9. PubMed ID: 12879228
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal functions of hepatocyte growth factor and transforming growth factor-beta1 in the progression of renal diseases: a role for CD44?
Florquin S; Rouschop KM
Kidney Int Suppl; 2003 Oct; (86):S15-20. PubMed ID: 12969122
[TBL] [Abstract][Full Text] [Related]
19. Analysis of soluble factors in conditioned media derived from primary cultures of cirrhotic liver of biliary atresia.
Yamazaki T; Wakai M; Enosawa S; Tokiwa T
In Vitro Cell Dev Biol Anim; 2017 Jun; 53(6):564-573. PubMed ID: 28364348
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
